A Functional Contributor to Cancer Metastatic Potential
In a recent study by Crawford et al. published in PNAS, it was shown that Brd4, a ubiquitously expressed 200-kDa nuclear protein broadly expressed in many tissues, significantly reduced tumor growth and metastasis when implanted into mice. Further, Microarray analysis performed by the same group identified a correlation between Brd4 activation and disease progression/patient survival.
Together, this evidence strongly suggests that Brd4 plays a key role in breast cancer progression and an underlying mechanism of many metastasis-predictive gene signatures.
Although it remains to be determined if Brd4's role is that of a proximal factor or an intermediary molecule of some other inherited factor that drives the progression of breast cancer, its functional importance is emerging as both a diagnostic and prognostic tool with therapeutic significance.
In a recent study by Crawford et al. published in PNAS, it was shown that Brd4, a ubiquitously expressed 200-kDa nuclear protein broadly expressed in many tissues, significantly reduced tumor growth and metastasis when implanted into mice. Further, Microarray analysis performed by the same group identified a correlation between Brd4 activation and disease progression/patient survival.
Together, this evidence strongly suggests that Brd4 plays a key role in breast cancer progression and an underlying mechanism of many metastasis-predictive gene signatures.
Although it remains to be determined if Brd4's role is that of a proximal factor or an intermediary molecule of some other inherited factor that drives the progression of breast cancer, its functional importance is emerging as both a diagnostic and prognostic tool with therapeutic significance.
